ALKBH5 and neoplasm: ALKBH5 in tumor cells recruits immune suppressive cells, including myeloid-derived suppressor cells (MDSCs) and Tregs, and facilitates lactate accumulation to regulate the anti-PD-1 therapy response depending on m6A in melanoma.